by admin | Nov 18, 2022 | News & Opinions
By Greg Slabodkin, ScienceBoard Editor in Chief The U.S. Food and Drug Administration (FDA) has elevated and reorganized its Office of Tissues and Advanced Therapies (OTAT) to a “Super Office” within the Center of Biologics Research and Evaluation (CBER) to meet its...
by admin | Nov 17, 2022 | News & Opinions
An experiment tests whether the gene-editing technology can stop the virus from replicating, which would ultimately wipe out the infection. By Wired.com In July, an HIV-positive man became the first volunteer in a clinical trial aimed at using Crispr gene editing to...
by admin | Nov 16, 2022 | News & Opinions
University of Edinburgh – Eurekalert.org Leprosy is one of the world’s oldest and most persistent diseases but the bacteria that cause it may also have the surprising ability to grow and regenerate a vital organ. Scientists have discovered that parasites...
by admin | Nov 16, 2022 | News & Opinions
By Jim Cornall – Labiotech.eu Sierra Space and University of California San Diego, one of the world’s top 15 research universities and a leader in microgravity research, have formed a new agreement with the goal of defining the future of human health care...
by admin | Nov 15, 2022 | News & Opinions
UK scientists have begun the first clinical trial of lab-grown red blood cells, with the hope that they survive longer in volunteers than donated blood cells. By Ed Cara – Gizmodo An important clinical trial is now underway in the UK. The study is the first to...
